Glioblastoma Therapeutics Network (U19 Clinical Trial Required)

0
486

Funding Opportunity ID:328818
Opportunity Number:RFA-CA-20-047
Opportunity Title:Glioblastoma Therapeutics Network (U19 Clinical Trial Required)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Education
Health
Category Explanation:
CFDA Number(s):93.394
93.395
Eligible Applicants:State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Aug 27, 2020
Close Date:Nov 19, 2020
Last Updated Date:Aug 27, 2020
Award Ceiling:$700,000
Award Floor:$0
Estimated Total Program Funding:
Expected Number of Awards:
Description:The overall goal of this funding opportunity announcement (FOA) is to improve the treatment of adult glioblastoma (GBM) by developing novel effective agents that can cross the blood-brain barrier (BBB) and testing them in the clinic. To implement this concept, multi-institution teams are invited to participate in the Glioblastoma Therapeutics Network (GTN). Each GTN team will be capable of driving therapeutic agent(s) from pre-clinical development, through IND studies, into pilot clinical studies in humans.
Version:1





Visit the Official Webpage For More Details on Glioblastoma Therapeutics Network (U19 Clinical Trial Required)

LEAVE A REPLY

Please enter your comment!
Please enter your name here